InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Koenig Scott, Director. Officer active across 3 companies, notably Glycomimetics INC. In total, 11 disclosures have been recorded. Activity tracked since 18 May 2021. The latest transaction was filed on 15 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
11 of 11 declarations
Scott Koenig is a Director at GLYCOMIMETICS INC and MACROGENICS INC. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for both GLYCOMIMETICS and MACROGENICS.